For the quarter ending 2025-09-30, CSTL made $83,043,000 in revenue. -$501,000 in net income. Net profit margin of -0.60%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net revenues | 83,043,000 | 86,188,000 | 87,988,000 | 79,642,500 |
| Cost of sales (exclusive of amortization of acquired intangible assets) | 18,704,000 | 17,626,000 | 16,383,000 | 15,038,500 |
| Research and development | 12,960,000 | 12,787,000 | 12,588,000 | 12,791,000 |
| Selling, general and administrative | 55,907,000 | 58,065,000 | 58,620,000 | 49,230,000 |
| Amortization of acquired intangible assets | 2,276,000 | 1,961,000 | 28,325,000 | 3,293,500 |
| Total operating expenses, net | 89,847,000 | 90,439,000 | 115,916,000 | 80,353,000 |
| Operating (loss) income | -6,804,000 | -4,251,000 | -27,928,000 | -710,500 |
| Interest income | 2,833,000 | 2,944,000 | 3,099,000 | 3,184,000 |
| Changes in fair value of equity securities | 3,561,000 | 1,185,000 | -1,425,000 | 277,500 |
| Interest expense | 24,000 | 21,000 | 17,000 | 53,000 |
| Other expense | 48,000 | - | - | - |
| (loss) income before income taxes | -386,000 | -143,000 | -26,271,000 | 2,698,000 |
| Income tax expense (benefit) | 115,000 | -4,666,000 | -423,000 | -830,000 |
| Net (loss) income | -501,000 | 4,523,000 | -25,848,000 | 3,528,000 |
| Basic (in dollars per share) | -0.02 | 0.16 | -0.9 | 0.13 |
| Basic (in shares) | 29,073,000 | 28,914,000 | 28,609,000 | -13,855,000 |
| Diluted (in dollars per share) | -0.02 | 0.15 | -0.9 | 0.115 |
| Diluted (in shares) | 29,073,000 | 29,545,000 | 28,609,000 | -14,442,000 |
CASTLE BIOSCIENCES INC (CSTL)
CASTLE BIOSCIENCES INC (CSTL)